HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-γ, and interleukin-4 responses to respiratory syncytial virus infection in infants and children

Journal of Infectious Diseases

Volumn 183, Issue 5, 2001, Pages 687-696

  Mbawuike, Innocent N ^a   Wells, Janet ^a   Byrd, Richard ^c   Cron, Stanley G ^b   Glezen, W Paul ^a,b   Piedra, Pedro A ^a,b  

^a Respiratory Pathogens Research Unit   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Kelsey Seybold Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HLA A ANTIGEN; INTERLEUKIN 4;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; EPIDEMIC; HUMAN; INFECTION CONTROL; INFECTION RATE; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; VIRUS CULTURE; VIRUS DETECTION;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CHILD, PRESCHOOL; COHORT STUDIES; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKIN-4; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SEASONS; T-LYMPHOCYTES, CYTOTOXIC; TEXAS;

EID: 0035282957     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/318815     Document Type: Article

References (42)

1. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity
2. Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells
3. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus
4. Respiratory syncytial virus infection in immunosuppressed animals: Implications in human infection
5. Viral infections in immunocompromised patients
6. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine
7. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis
8. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection
9. Immunological determinants of disease caused by respiratory syncytial virus
10. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus
11. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology
12. Respiratory syncytial virus-induced interleukin-4 production by human conjunctival epithelial cells contributes to allergy: Preliminary study
13. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells
14. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response
15. Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus
16. IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness
17. Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons
18. Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine
19. HLA restriction of human cytotoxic T lymphocytes specific for influenza virus: Poor recognition of virus associated with HLA-A2
20. In vitro effects of cryoprotective agents on the response of murine T and B lymphoid subpopulations to mitogenic agents
21. Immunological responsiveness of frozen-thawed human lymphocytes
22. Cryopreservation of human lymphocyte function as measured by in vitro assays
23. Cytotoxicity inhibition assay: Cryopreservation and standardization: Brief communication
24. + T cells
25. Analysis of human antiviral cytotoxic T-lymphocyte responses for vaccine trials using cryopreserved mononuclear leukocytes: Demonstration of feasibility with influenza virus-specific responses
26. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin
27. Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): The Western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection
28. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis
29. HLA class I antigens in severe RSV bronchiolitis
30. Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants
31. Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus
32. + cytotoxic T lymphocytes
33. Effect of cryopreservation on lymphocyte markers evaluated by monoclonal antibodies
34. + CTL activity among elderly persons and the enhancing effect of IL-12
35. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis
36. Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis
37. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
38. Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia
39. + memory T cells
40. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection
41. Helper T cell recognition of respiratory syncytial virus in mice
42. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism